Search filters

List of works by Timothy Perren

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study ⬇️

scientific article published on 30 August 2016

A Phase 3 Trial of Bevacizumab in Ovarian Cancer ⬇️

scientific article published on December 29, 2011

A functional form for a representative individual arterial input function measured from a population using high temporal resolution DCE MRI

scientific article published on 26 September 2018

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial

scientific article published in May 2004

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer ⬇️

scientific article published on August 2004

A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma ⬇️

scientific article

A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer

scientific article published on 03 March 2011

A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis

scientific article published on 01 January 2011

A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trial.

scientific article published on 21 January 2010

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group. ⬇️

scientific article

Anthracycline-induced cardiomyopathy in siblings with early breast cancer

scientific article published on 09 May 2011

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

scientific article

Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? ⬇️

scientific article published on December 2002

CT appearances and prognostic significance of splenic metastasis in ovarian cancer

scientific article published in June 1998

CT demonstration of calcified metastatic mediastinal lymph nodes

scientific article published on 01 December 1998

Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology Group

scientific article published on 01 January 1990

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.

scientific article

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit ⬇️

scientific article

Chemotherapy for ovarian cancer--a consensus statement on standard practice. ⬇️

scientific article published on December 1998

Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. ⬇️

scientific article

Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20 ⬇️

scientific article published on June 19, 1998

Development of antiangiogenic agents for ovarian cancer.

scientific article published on January 2008

Discordance between the results and conclusions of ICON7 - Authors' reply

scientific article published in October 2015

Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.

scientific article

Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist.

scientific article published on 7 April 2016

Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood

scientific article published in September 1996

Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease ⬇️

scientific article published on June 1, 1990

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer ⬇️

scientific article published on 16 November 2018

Feasibility and compliance of automated measurement of quality of life in oncology practice

scientific article published in January 2003

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study.

scientific article published on 18 June 2010

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

scientific article

Good manners for the pharmaceutical industry

High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum

scientific article published on 02 June 2019

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. ⬇️

scientific article

High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's disease.

scientific article

Image-guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis

scientific article published in January 2006

Implications of ejection fraction value for trastuzumab

scientific article published in September 2006

Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK. ⬇️

scientific article published on 9 July 2016

Lymphomas of the cervix and upper vagina: A report of five cases and a review of the literature ⬇️

scientific article published on January 1, 1992

Mucinous epithelial ovarian carcinoma. ⬇️

scientific article published on April 2016

Mucinous tumours of the ovary.

scientific article published on 19 October 2011

Multiple myeloma treated with high dose intravenous melphalan

scientific article published on 01 May 1987

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

scientific article published on 06 November 2018

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

scientific article published on 01 March 2006

Ovarian cancer: advances in first-line treatment strategies with a particular focus on anti-angiogenic agents.

scientific article published on December 2012

Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience. ⬇️

scientific article

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study.

scientific article published on June 2004

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study

scientific article published in May 2005

Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests

scientific article published in September 2000

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.

scientific article published on 19 May 2015

Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer

scientific article published in December 2007

Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer.

scientific article

Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study

scientific article published on 27 November 2019

Routine chest radiography following imaging-guided placement of tunneled central lines: a waste of time, money, and radiation.

scientific article

Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment. ⬇️

scientific article published on 20 April 2016

Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects

scientific article published in April 2000

Targeted anti-vascular therapies for ovarian cancer: current evidence ⬇️

scientific article

The Cost-Effectiveness of Bevacizumab in Advanced Ovarian Cancer Using Evidence from the ICON7 Trial.

scientific article

The Cytotoxics Handbook.

scientific article

The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy ⬇️

scientific article published on 15 June 2016

The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation ⬇️

scientific article

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. ⬇️

scientific article

The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancer. ⬇️

scientific article published on October 1990

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.

scientific article published on 23 July 2007

Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide

scientific article published on 01 January 1989

WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis.

scientific article published on 13 January 2010

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

scientific article published on 29 November 2019

Women with peritoneal carcinomatosis of unknown origin: Efficacy of image-guided biopsy to determine site-specific diagnosis.

scientific article published on January 2007

c-erbB-2 oncogene as a prognostic marker in breast cancer ⬇️

scientific article published on March 1, 1991

p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial

article

Paulina is supported by:

About Paulina

Help